ArticleOncotarget2017

Combined MEK and Pi3'-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo.

Oussama ElMokh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.